AMWL vs. TRAK, CNDT, IBEX, ADV, TSSI, OOMA, ABSI, IMXI, ZH, and LTBR
Should you be buying American Well stock or one of its competitors? The main competitors of American Well include Repositrak (TRAK), Conduent (CNDT), IBEX (IBEX), Advantage Solutions (ADV), TSS (TSSI), Ooma (OOMA), Absci (ABSI), International Money Express (IMXI), Zhihu (ZH), and Lightbridge (LTBR). These companies are all part of the "business services" industry.
American Well vs. Its Competitors
American Well (NYSE:AMWL) and Repositrak (NYSE:TRAK) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.
American Well has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Repositrak has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500.
56.0% of American Well shares are owned by institutional investors. Comparatively, 27.4% of Repositrak shares are owned by institutional investors. 11.8% of American Well shares are owned by insiders. Comparatively, 44.0% of Repositrak shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Repositrak has a net margin of 0.00% compared to American Well's net margin of -81.83%. Repositrak's return on equity of 0.00% beat American Well's return on equity.
American Well presently has a consensus target price of $9.67, indicating a potential upside of 35.96%. Given American Well's stronger consensus rating and higher possible upside, equities research analysts plainly believe American Well is more favorable than Repositrak.
Repositrak has lower revenue, but higher earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Repositrak, indicating that it is currently the more affordable of the two stocks.
American Well received 32 more outperform votes than Repositrak when rated by MarketBeat users. However, 100.00% of users gave Repositrak an outperform vote while only 40.24% of users gave American Well an outperform vote.
In the previous week, Repositrak had 11 more articles in the media than American Well. MarketBeat recorded 13 mentions for Repositrak and 2 mentions for American Well. American Well's average media sentiment score of 0.56 beat Repositrak's score of 0.42 indicating that American Well is being referred to more favorably in the media.
Summary
Repositrak beats American Well on 10 of the 18 factors compared between the two stocks.
Get American Well News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMWL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AMWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
American Well Competitors List
Related Companies and Tools
This page (NYSE:AMWL) was last updated on 6/11/2025 by MarketBeat.com Staff
